MMP-1 promoter polymorphism is associated with risk of radiation-induced lung injury in lung cancer patients treated with radiotherapy
Open Access
- 21 September 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (43) , 70175-70184
Abstract
MMP-1 promoter polymorphism is associated with risk of radiation-induced lung injury in lung cancer patients treated with radiotherapyKeywords
This publication has 35 references indexed in Scilit:
- In vitro effects of infrared A radiation on the synthesis of MMP-1, catalase, superoxide dismutase and GADD45 alpha proteinInflammation & Allergy - Drug Targets, 2015
- Genetic variants in PI 3K/ AKT pathway are associated with severe radiation pneumonitis in lung cancer patients treated with radiation therapyCancer Medicine, 2015
- Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumoniasRespiratory Medicine, 2015
- Thoracic radiotherapy improves survival in small-cell lung cancerNature Reviews Clinical Oncology, 2014
- Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case–control study in a Spanish populationCoronary Artery Disease, 2009
- A novel role for the TRPV1 channel in UV‐induced matrix metalloproteinase (MMP)‐1 expression in HaCaT cellsJournal of Cellular Physiology, 2009
- MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary FibrosisPLOS Medicine, 2008
- Haplotype Effects on Matrix Metalloproteinase-1 Gene Promoter Activity in Cancer CellsMolecular Cancer Research, 2007
- Extracellular Regulated Kinase/Mitogen Activated Protein Kinase Is Up-regulated in Pulmonary Emphysema and Mediates Matrix Metalloproteinase-1 Induction by Cigarette SmokeJournal of Biological Chemistry, 2004
- Variation in the matrix metalloproteinase-1 gene and risk of coronary heart diseaseEuropean Heart Journal, 2003